Signs point to FDA approval for Biogen’s experimental Alzheimer’s disease treatment, though there are skeptics - MarketWatch

1. Signs point to FDA approval for Biogen’s experimental Alzheimer’s disease treatment, though there are skeptics  MarketWatch
2. Biogen Alzheimer's drug closer to approval  Reuters
3. Doctors view Biogen Alzheimer's drug favorably after reviewing documents  STAT
4. Controversial Alzheimer’s drug gets boost from FDA staff  The Washington Post
5. Option Trader Bets $2.5M On Biogen After FDA's Favorable Alzheimer's Drug Support  Yahoo Finance
6. View Full Coverage on Google News

from Business - Latest - Google News https://ift.tt/3p4ya6G